HempNewsBreaks – Canbiola, Inc. (CANB) Names New Medical Advisory Board Member

Canbiola (OTC PINK: CANB) today announced the addition of Dr. David J. Weissberg to the company’s medical advisory board. Dr. Weissberg also signed on as a private label customer. Today’s update agrees with Canbiola’s ongoing effort to attract and partner with global health and wellness industry experts. With over 25 years in private practice, Dr. Weissberg specializes in a meticulous and moderate approach to orthopedic care. He is also a co-owner of the Melville Surgery Center and certified in the ImPACT™ (Immediate Post-Concussion Assessment and Cognitive Testing) Protocol. “We are continuing to execute our plan to strengthen not only our Medical Advisory Board but also our distribution network. With the addition of Dr. Weissberg, we have added the 8th doctor to our Medical Advisory Board. I believe this addition will benefit our product development, to have true medical experts advise and offer input as we develop new products is an invaluable resource. Coupling the continued and increased acceptance of CBD with our development of new products for different uses will continue our growth and sales while expanding our client base. At Canbiola we are building an extraordinary team, and look to be an industry leader going forward. My enthusiasm for our future and the direction of the industry as a whole is very strong, I want to thank our team and shareholders for their support,” Canbiola CEO Marco Alfonsi stated in the news release.

To view the full press release, visit http://cnw.fm/mcD1G

About Canbiola, Inc.

Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola is in the process of developing its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states. The company has already launched several products. For more information, visit the company’s website at www.Canbiola.com.

More from CannabisNewsBreaks

• HempNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model
• HempNewsBreaks – CannabisNewsWire Named Official Newswire of 2025 Cannabis Means Business Expo in NYC 
• HempNewsBreaks – Turning Point Brands Inc. (NYSE: TPB) Closes $300M Senior Secured Notes Offering 

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net